We noticed you’re blocking ads

Thanks for visiting CRSTG | Europe Edition. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstodayeurope.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Up Front | May 2007

Custom Ablation for Irregular Astigmatism

We studied highly irregular corneas to address the special requirements of treating complex cases with irregular astigmatism.

Consistent technological and surgical skill improvements have led to excellent outcomes and very low enhancement rates in modern laser refractive surgery. Consequently, most surgeons' refractive experience is limited to treatments in mainly uncomplicated virgin cases. Unfortunately, when we apply the same reasoning and technology to complex secondary cases with irregular astigmatism, results become more inconsistent, and cases may even deteriorate.

There could be several reasons why the common technology and techniques that work so well on virgin eyes do not work as well in the treatment of irregular astigmatism. First, the most current diagnostic equipment for custom data acquisition is often not capable of detecting all the necessary features of an irregular cornea, since it is fine-tuned to detect details in virgin eyes. Second, the software's ablation-planning strategy assumes optimization of intact preoperative optics and not a restoration of distorted optics. Finally, surgical techniques and equipment are for treatment of virgin eyes.

In an ongoing study at the University Hospital of North Norway, in Tromsø, we attempted to circumvent the above-mentioned obstacles and address the special requirements that we thought were necessary to treat complex cases with irregular astigmatism. First, we found the optimal method of registering relevant preoperative information in eyes with irregular astigmatism. After a decentration of corneal optics, the eye attempts to compensate for the visual distortion and rotates into a new fixating position. This results in a change of corneal intercept and inclination of fixation axis (Figures 1 and 2). Consequently, a map of a fixating eye with decentered optics, acquired by monocular placido topography and/or aberrometry, would give us a reference to the eye position, as previously described. It would also constrain our treatment options to optimization of the corneal/eye optics reflecting that position and possibly lead to unnecessary corneal tissue consumption.1 Therefore, we based our custom data on corneal morphology (ie, altimetry data), mapped independently of the rotational position of a fixating eye. For that purpose, we used elevation topography maps (calculated by triangulation) instead of wavefront aberrometry or monocular placido-based topography that provides a single shot of the eye/corneal optics bound to the line of sight or fixation axis, respectively.

For custom ablation planning, we used Corneal Interactive Programmed Topographic Ablation (CIPTA; Ligi, SpA, Taranto, Italy), instead of wavefront-based software, which is common for treatment of virgin eyes. CIPTA compiled an ablation pattern, aiming to transform the actual corneal shape into a regular aspheric shape of desired curvature with a customized transition toward the untreated area. CIPTA software allows customization of parameters including tilt, centration, asphericity, and optical and transition size. The surgeon may then choose and fit the desired corneal shape in a variety of ways.

In our study of highly irregular corneas, we chose the morphological axis (ie, a computer-generated approximation of the primary optical symmetry of the cornea) as the ablation-fitting axis, since it seems to be the least invasive approach.1 To achieve the smoothest transition toward the untreated cornea, the software customizes the transition area, providing a constant gradient of curvature change more than 360º by taking into account corneal shape outside the ablation area. As a preferred surgical technique for treatment of irregular astigmatism, we used transepithelial surface ablation; the epithelial removal with excimer laser was an integral part of the ablation plan. We added a constant 75-µm ablation depth to the compiled custom ablation plan to allow for maximum epithelial thickness. Alternatively, Artemis measurements (Ultralink LLC, St. Petersburg, Florida) of the actual maximum epithelial thickness were used in patients who underwent that examination. A modified LaserSight AstraScan (LaserSight Technologies, Inc., Winter Park, Florida) excimer laser was used for treatments. It is a flying spot laser system with a 0.6-mm Gaussian spot, 200-Hz frequency, and video-based eye tracker. The laser modification concerned its ability to read ablation maps generated by CIPTA within a matrix of 10,000 points, with the pupil center used as a common reference point between CIPTA and the laser. Additionally, to avoid cyclotorsional error, the CIPTA protocol required definition of horizontal axis during all relevant preoperative examinations, as well as the cyclotorsional alignment of the eye during the treatment. These were with respect to defined horizontal axis.

We studied 100 eyes (100 patients) treated for visual disturbances after decentered ablation, irregular ablation, insufficient effective optical zone, interface irregularities, irregular astigmatism after other types of eye surgery, injuries, and keratitis. Patients were recruited through referral by other eye departments, private clinics, or practicing ophthalmologists in Norway or abroad. Indications for treatment were visual disturbances related to changes in corneal topography that were categorized into the following three groups: (1) multiplopia and halos, (2) night vision disturbances including glare and starburst, and (3) decreased UCVA by spectacles or soft contact lenses. Correlation between the symptoms and the main corneal topography feature are summarized in Table 1. Topographic changes were analyzed by comparing preoperative and postoperative maps as well as simulated and achieved outcome maps.

Twelve months after surgery, no eye available for evaluation lost lines of BSCVA (n=66), while 50% gained lines, and 26% gained two or more lines. The safety index (ie, ratio between post- and preoperative BSCVA) was 1.27. Low-contrast BCVA improved by 58% (mean, 0.45 to 0.77; decimal scale converted from logMAR). The measured efficacy of our treatment was the amount of visual disturbances after the surgery. Table 2 shows the experienced change in visual disturbances compared with the preoperative level.

CASE STUDY
A 30-year-old male special force policeman with low myopia and 7-mm scotopic pupil was first treated with bilateral LASIK 12 months before referral to our clinic. The surgery was uneventful, except for a free—allegedly well-repositioned—cap in his right eye. His postoperative UCVA was 20/20, and he was near emmetropic in both eyes. The patient was seriously disturbed by multiple images, halos, and night vision problems in his right eye, which led to disability leave.

Corneal topography of his right eye showed a relatively well-centered ablation, but there were numerous paracentral irregularities, and the corneal asphericity was oblate with a Q-index of 0.87. Both first-surface Zernike analysis of elevation topography and wavefront aberrometry showed a significant increase in higher-order aberrations, especially fifth- and third-orders, as well as increased positive spherical aberration. Wavefront aberrometry showed root mean square of higher-order aberration coefficients six to 20 at 9.01 µm (Figure 3). We concluded that the most probable cause of this patient's irregular astigmatism was an erroneously repositioned (rotated) free cap. Transepithelial ablation on top of the LASIK flap was performed, aiming for a new optical surface. We used restored morphological axis mode of the CIPTA software. The ablation map and simulated outcome are shown in Figure 4.

Twelve months after surgery, most of the patient's visual disturbances were eliminated, and near emmetropia was preserved. Q-index changed from oblate (0.87) to prolate
(-0.32), and wavefront aberrometry showed an approximate 500% decrease in higher-order aberrations (Figure 5). The patient returned to his original job 1 month after surgery.

DISCUSSION
Wavefront technology has primarily been created for, and seems to be capable of achieving, excellent results in virgin eyes. After the initial enthusiasm and expectation that it would provide a cure for any type of refractive error, wavefront-guided custom ablation has fallen somewhat short of being able to treat complex cases with visually disturbing irregular astigmatism. Recent evidence shows that Zernike representation of local irregularities (ie, used in current wavefront-guided technology) may be inadequate for complex wavefront distortions and that visual symptoms do not correlate well with wavefront data in such cases. Aberrometry maps do not cover the area beyond the pupil, which may be problematic when treating visual disturbances traceable to aberrations caused by corneal changes outside the aberrometry-measurable area.

Because changes in the cornea led to the irregular astigmatism that caused visual disturbances, the corneal surface elevation map should be the most appropriate source of information, rather than wavefront aberrometry from the whole optical system. Yet, the early custom ablation systems that used corneal topography, introduced in mid 1990s, reported only limited success. Combination of low-precision diagnostics of the monocular placido-disk–based topographers (ie, compiling corneal elevation maps from curvature data, by use of the arc step method, with an inherent cumulative error), inappropriate ablation planning software, and low-resolution lasers (ie, with spot size greater than 1 mm), were probable reasons for the failure of those pioneer systems. In this study, corneal topography-guided custom ablation involving elevation topography generated by use of triangulation, a versatile ablation planning software, and a 200-Hz eye-tracking laser with a 0.6-mm flying spot were used.

We treated all study eyes with surface ablation to maximally preserve corneal tissue, because it is a rare commodity in secondary cases. The transepithelial ablation surgical technique included laser ablation of epithelium as an integral part of the ablation plan. It was not only the least traumatic way of dealing with epithelium in surface ablation, but it customized a minimum area for deepithelialization, something that significantly reduced reepithelialization time and patient discomfort.

Most importantly, transepithelial ablation is the only reliable way to perform surface custom ablation on secondary cases where significant epithelial remodelling is expected to occur. In such cases, topography—or wavefront—data would differ significantly if measured with and without epithelium. If traditional deepithelialization techniques were used, we would be treating quite a different topography or wavefront than the one that we based our custom ablation plan on. This would result in unpredictable outcomes. The transepithelial ablation technique requires not only the software that would add a stipulated (or Artemis-measured) maximum epithelial depth to the custom ablation plan, but also a fast laser with a spot and energy distribution that results in a smooth ablation surface.

The last-mentioned feature may be the most important, because of its impact on minimizing the chances of postop haze. Our clinic has upgraded to a 1,000-Hz IVis-Suite laser (Ligi, SpA), which is actually built with custom transepithelial surface ablation in mind, so that it creates a smoother surface in a fraction of the time, when compared with the system used in this study.

One remaining problem with the topography-guided approach is that the spherocylindrical portion of the treatment, which is necessary to achieve the aimed refractive endpoint, relies on measuring the subjective refraction in the midst of higher-order aberrations, omnipresent in cases with irregular astigmatism. Unfortunately, wavefront aberrometry measurements, which should ideally provide objective information on lower-order aberrations, seem to lack reliability in highly aberrated cases, if at all possible to be acquired. Our treatments showed a high level of safety and efficacy. Most importantly, our patients' preoperative visual disturbances were decreased or eliminated.

Aleksandar Stojanovic, MD, is in charge of refractive surgery at the Eye Department, University Hospital of North Norway, in Tromsø. Dr. Stojanovic states that he has no financial interest in the products or companies mentioned. He may be reached at tel: +47 90 69 33 19; fax: +47 77 64 79 29; or aleks@online.no.

NEXT IN THIS ISSUE